OptimizeRx Corporation (OPRX): Price and Financial Metrics

OptimizeRx Corporation (OPRX): $14.62

-0.52 (-3.43%)

POWR Rating

Component Grades














  • Growth is the dimension where OPRX ranks best; there it ranks ahead of 59.15% of US stocks.
  • The strongest trend for OPRX is in Value, which has been heading up over the past 177 days.
  • OPRX ranks lowest in Sentiment; there it ranks in the 11th percentile.

OPRX Stock Summary

  • The price/operating cash flow metric for OPTIMIZERX CORP is higher than 95.53% of stocks in our set with a positive cash flow.
  • The ratio of debt to operating expenses for OPTIMIZERX CORP is higher than it is for about only 4.97% of US stocks.
  • Over the past twelve months, OPRX has reported earnings growth of -984.98%, putting it ahead of just 1.69% of US stocks in our set.
  • Stocks that are quantitatively similar to OPRX, based on their financial statements, market capitalization, and price volatility, are PRPO, LEV, ASLE, XOMA, and EVR.
  • OPRX's SEC filings can be seen here. And to visit OPTIMIZERX CORP's official web site, go to www.optimizerx.com.

OPRX Valuation Summary

  • OPRX's price/earnings ratio is -38.3; this is 279.81% lower than that of the median Technology stock.
  • OPRX's price/sales ratio has moved up 1.8 over the prior 52 months.

Below are key valuation metrics over time for OPRX.

Stock Date P/S P/B P/E EV/EBIT
OPRX 2022-09-16 4.2 1.9 -38.3 -25.8
OPRX 2022-09-15 4.4 2.0 -40.2 -27.7
OPRX 2022-09-14 4.4 2.0 -40.7 -28.2
OPRX 2022-09-13 4.3 2.0 -40.0 -27.5
OPRX 2022-09-12 4.5 2.1 -41.5 -29.0
OPRX 2022-09-09 4.5 2.0 -41.3 -28.8

OPRX's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • OPRX has a Quality Grade of C, ranking ahead of 30.75% of graded US stocks.
  • OPRX's asset turnover comes in at 0.553 -- ranking 289th of 561 Business Services stocks.
  • BCOV, GEG, and BBSI are the stocks whose asset turnover ratios are most correlated with OPRX.

The table below shows OPRX's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.553 0.556 0.063
2021-03-31 0.628 0.551 -0.069
2020-12-31 0.761 0.557 -0.329
2020-09-30 0.612 0.583 -1.514
2020-06-30 0.529 0.591 -2.408
2020-03-31 0.511 0.599 -1.769

OPRX Price Target

For more insight on analysts targets of OPRX, see our OPRX price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $73.33 Average Broker Recommendation 1.4 (Strong Buy)

OPRX Stock Price Chart Interactive Chart >

Price chart for OPRX

OPRX Price/Volume Stats

Current price $14.62 52-week high $99.18
Prev. close $15.14 52-week low $13.33
Day low $14.58 Volume 33,354
Day high $15.15 Avg. volume 220,999
50-day MA $17.56 Dividend yield N/A
200-day MA $32.97 Market Cap 265.38M

OptimizeRx Corporation (OPRX) Company Bio

OptimizeRx Corporation operates an Internet website through which it offers advice to consumers on how to save money on branded prescription and over-the-counter healthcare products.

OPRX Latest News Stream

Event/Time News Detail
Loading, please wait...

OPRX Latest Social Stream

Loading social stream, please wait...

View Full OPRX Social Stream

Latest OPRX News From Around the Web

Below are the latest news stories about OPTIMIZERX CORP that investors may wish to consider to help them evaluate OPRX as an investment opportunity.

Is OptimizeRx Corporation (NASDAQ:OPRX) Potentially Undervalued?

OptimizeRx Corporation ( NASDAQ:OPRX ), is not the largest company out there, but it saw significant share price...

Yahoo | September 23, 2022

OptimizeRx Extends Exclusive Partnership with ePrescribing Leader Therapy Brands

Innovative best-in-class technology solutions continue to offer HCPs a seamless prescribing experience within the EHR workflow ROCHESTER, Mich., Sept. 20, 2022 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on therapy announced a renewed exclusive partnership agreement with Therapy Brands, leveraging their NewCrop solution, a leading electronic prescribing service trusted by hundreds of

Yahoo | September 20, 2022

OptimizeRx to Participate in Upcoming September Conferences

ROCHESTER, Mich., Sept. 07, 2022 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on therapy, announced today that management will participate in the following September conferences on the following days: R.W. Baird Healthcare Conference, New York City, September 13Lake Street BIG6 Investor Conference, New York City, September 14LifeSci Health Tech Symposium, Virtual, September 21 Confere

Yahoo | September 7, 2022

OptimizeRx Reports Results of Flagship Evidence-Based Physician Engagement Program

Analysis finds patent-pending real-world evidence solution successful in identifying HCPs with patients at risk of non-adherence due to unexpected cost. Proactive affordability messaging key for doctors and patients navigating Medicare coverage gaps ROCHESTER, Mich., Aug. 23, 2022 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on therapy demonstrates strong impact for life sciences bran

Yahoo | August 23, 2022

Chief Commercial Officer Stephen Silvestro Just Bought A Handful Of Shares In OptimizeRx Corporation (NASDAQ:OPRX)

Whilst it may not be a huge deal, we thought it was good to see that the OptimizeRx Corporation ( NASDAQ:OPRX ) Chief...

Yahoo | August 19, 2022

Read More 'OPRX' Stories Here

OPRX Price Returns

1-mo -7.41%
3-mo -47.47%
6-mo -62.79%
1-year -80.50%
3-year 0.97%
5-year 1,079.03%
YTD -76.46%
2021 99.33%
2020 203.41%
2019 -6.38%
2018 598.73%
2017 93.83%

Continue Researching OPRX

Here are a few links from around the web to help you further your research on OptimizeRx Corp's stock as an investment opportunity:

OptimizeRx Corp (OPRX) Stock Price | Nasdaq
OptimizeRx Corp (OPRX) Stock Quote, History and News - Yahoo Finance
OptimizeRx Corp (OPRX) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Page generated in 0.4682 seconds.